Total Payments
$3.7M
2024 Payments
$344,814
Companies
45
Transactions
3,840
Medicare Patients
3,024
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$2.0M (53.8%)
Consulting$1.1M (29.5%)
Travel$501,445 (13.7%)
Food & Beverage$75,457 (2.1%)
Research$29,135 (0.8%)
Education$1,415 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.0M | 823 | 53.5% |
| Consulting Fee | $1.1M | 318 | 29.5% |
| Travel and Lodging | $501,445 | 1,035 | 13.7% |
| Food and Beverage | $75,457 | 1,591 | 2.1% |
| Unspecified | $29,135 | 23 | 0.8% |
| Honoraria | $13,800 | 5 | 0.4% |
| Education | $1,415 | 45 | 0.0% |
Payments by Type
General
$3.6M
3,817 transactions
Research
$29,135
22 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $987,621 | 842 | $0 (2024) |
| Lilly USA, LLC | $498,065 | 625 | $0 (2024) |
| UCB, Inc. | $317,889 | 324 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $264,860 | 305 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $259,442 | 289 | $0 (2024) |
| GENZYME CORPORATION | $257,263 | 197 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $212,804 | 140 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $204,426 | 217 | $0 (2019) |
| Amgen Inc. | $182,713 | 266 | $0 (2024) |
| Eli Lilly and Company | $86,751 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $344,814 | 298 | ABBVIE INC. ($169,418) |
| 2023 | $503,053 | 435 | AbbVie Inc. ($213,751) |
| 2022 | $395,466 | 347 | ABBVIE INC. ($204,204) |
| 2021 | $453,659 | 432 | AbbVie Inc. ($197,196) |
| 2020 | $374,951 | 363 | AbbVie Inc. ($87,484) |
| 2019 | $562,737 | 669 | AbbVie, Inc. ($97,066) |
| 2018 | $571,294 | 653 | Lilly USA, LLC ($105,708) |
| 2017 | $446,781 | 643 | E.R. Squibb & Sons, L.L.C. ($91,164) |
All Payment Transactions
3,840 individual payment records from CMS Open Payments — Page 1 of 154
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| 12/17/2024 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,650.00 | General |
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Immunology | ||||||
| 12/13/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $247.68 | General |
| Category: Immunology | ||||||
| 12/13/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $247.67 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $667.77 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $263.48 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $263.48 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $146.34 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $124.62 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $124.62 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $93.74 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Consulting Fee | Cash or cash equivalent | $1,908.00 | General |
| Category: Rheumatology | ||||||
| 11/27/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: Rheumatology | ||||||
| 11/27/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | Lilly USA, LLC | TALTZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Lilly USA, LLC | TALTZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: Immunology | ||||||
| 11/22/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TOFACITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $13,300 | 10 |
| RESEARCH RELATED PUBLICATIONS SUPPORT | Novartis Pharmaceuticals Corporation | $8,750 | 1 |
| Data-driven patient clustering and differential clinical outcomes in the BRASS rheumatoid arthritis registry | SANOFI-AVENTIS U.S. LLC | $959.04 | 2 |
| A randomized, double-blind, parallel-group study assessing the efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis | GENZYME CORPORATION | $893.33 | 1 |
| Exploring Heterogeneity in Rheumatoid Arthritis: Outcomes up to 4 Years of Follow-Up in Patient Clusters Identified by Data-driven Analysis of The BRASS Registry | SANOFI-AVENTIS U.S. LLC | $748.00 | 2 |
| Exploring Heterogeneity in Rheumatoid Arthritis: Patient Profiling through Principal Component and Cluster Analysis of The Brass Registry | SANOFI-AVENTIS U.S. LLC | $612.00 | 2 |
| Association Between Changes in C-reactive Protein at Week 12 With Sarilumab Therapy and Patient-reported Outcomes at Week 24 Across Three Pivotal Phase 3 Studies | SANOFI-AVENTIS U.S. LLC | $353.33 | 1 |
| Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women?s Rheumatoid Arthritis Sequential Study (BRASS) Registry | SANOFI-AVENTIS U.S. LLC | $226.44 | 1 |
| Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Womens Rheumatoid Arthritis Sequential Study (BRASS) Registry | SANOFI-AVENTIS U.S. LLC | $146.52 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 723 | 8,525 | $811,390 | $249,546 |
| 2022 | 18 | 774 | 8,594 | $777,795 | $246,147 |
| 2021 | 16 | 693 | 8,144 | $706,012 | $230,841 |
| 2020 | 20 | 834 | 13,870 | $1.4M | $494,614 |
Total Patients
3,024
Total Services
39,133
Medicare Billing
$1.2M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 55 | 5,460 | $180,180 | $100,578 | 55.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 730 | $292,000 | $80,193 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 122 | $57,950 | $18,040 | 31.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 12 | 82 | $38,786 | $10,085 | 26.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 22 | 130 | $39,390 | $7,812 | 19.8% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2023 | 13 | 1,008 | $50,400 | $7,503 | 14.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 32 | 98 | $43,120 | $5,697 | 13.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 20 | 135 | $23,760 | $3,592 | 15.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $11,730 | $3,244 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 34 | $11,900 | $2,781 | 23.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 123 | 276 | $9,108 | $2,318 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $9,075 | $2,204 | 24.3% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 30 | 30 | $19,800 | $1,805 | 9.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 56 | 93 | $7,161 | $1,168 | 16.3% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Office | 2023 | 31 | 31 | $3,100 | $1,134 | 36.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 38 | 118 | $5,900 | $1,096 | 18.6% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 23 | 146 | $8,030 | $295.68 | 3.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 56 | 5,880 | $194,040 | $100,571 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 176 | 674 | $264,140 | $75,540 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 62 | 132 | $61,894 | $20,925 | 33.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 17 | 87 | $41,151 | $11,679 | 28.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 22 | 98 | $29,694 | $6,318 | 21.3% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2022 | 11 | 721 | $36,050 | $5,674 | 15.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 33 | 88 | $38,720 | $5,089 | 13.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 56 | $19,553 | $4,728 | 24.2% |
About Dr. Grace Wright, MD
Dr. Grace Wright, MD is a Rheumatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245240274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grace Wright, MD has received a total of $3.7M in payments from pharmaceutical and medical device companies, with $344,814 received in 2024. These payments were reported across 3,840 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2.0M).
As a Medicare-enrolled provider, Wright has provided services to 3,024 Medicare beneficiaries, totaling 39,133 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location New York, NY
- Active Since 08/09/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245240274
Products in Payments
- RINVOQ (Biological) $644,285
- TALTZ (Drug) $224,422
- COSENTYX (Biological) $218,206
- SAPHNELO (Biological) $204,818
- Cimzia (Drug) $192,865
- KEVZARA (Drug) $175,907
- KEVZARA (Biological) $158,201
- KEVZARA SARILUMAB INJECTION (Biological) $155,444
- ORENCIA (Biological) $151,270
- Enbrel (Biological) $105,044
- XELJANZ (Drug) $72,964
- OLUMIANT (Drug) $68,759
- RINVOQ (Drug) $65,790
- ACTHAR (Biological) $57,218
- Rinvoq (Biological) $52,646
- Bimzelx (Biological) $39,462
- Humira (Biological) $36,145
- TREMFYA (Drug) $34,613
- SKYRIZI (Biological) $29,496
- AIN457F_COSENTYX_IMMUNOLOGY (Biological) $20,930
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in New York
Laurie Glimcher, Md, MD
Rheumatology — Payments: $8.3M
Rheumatology $8.3M
Sergio Schwartzman, M.d, M.D
Rheumatology — Payments: $3.5M
Rheumatology $3.5M
Dr. Allan Gibofsky, Md, MD
Rheumatology — Payments: $2.4M
Rheumatology $2.4M
Petros Efthimiou, Md, MD
Rheumatology — Payments: $1.2M
Rheumatology $1.2M
Dr. Olga Petryna, Md, MD
Rheumatology — Payments: $548,960
Rheumatology $548,960
Dr. Danielle Petersel, M.d, M.D
Rheumatology — Payments: $462,362
Rheumatology $462,362